organ transplant
A growing volume of preclinical data linking dysbiosis to unfavorable solid organ transplant outcomes such as graft rejection is fueling calls for more rigorous research.
Xenotransplant Responses, Interactions Unraveled With Multiomic Analyses
Researchers tracked molecular consequences of transplanting genetically modified pig hearts into two brain-dead recipients, identifying distinct effects in each.
Natera Reports 52 Percent Spike in Q1 Revenues, Raises Full-Year Guidance
The company beat analysts' estimates on the top and bottom lines with growth driven by increased testing volumes and improvements in average test selling price.
Craig-Hallum Upgrades CareDx to Buy
Analyst Bill Bonello said CareDx has substantially de-risked its business and could benefit from Medicare coverage of kidney transplant surveillance testing.
Craig-Hallum Initiates Coverage of Natera With Buy Rating
Analyst Bill Bonello noted growth potential across Natera's markets, along with potential risks related to reimbursement, competition, and profitability.